Efficacy and Safety of Thrombolysis and Catheter-Directed Therapy in Pulmonary Embolism
Author Information
Author(s): Muacevic Alexander, Adler John R, Upadhyay Henil, Barnes Jonathan, Beattie Anna, Reicher John
Primary Institution: Newcastle Upon Tyne Hospitals NHS Foundation Trust
Hypothesis
This narrative review aims to explore the efficacy and safety of systemic thrombolysis and catheter-directed therapy in pulmonary embolism.
Conclusion
The review indicates that catheter-directed therapy improves right ventricular function and reduces bleeding episodes and mortality in pulmonary embolism patients.
Supporting Evidence
- Catheter-directed therapy has been shown to improve right ventricular function.
- Systemic thrombolysis can reduce mortality in high-risk pulmonary embolism patients.
- Current guidelines recommend aggressive treatment for intermediate and high-risk pulmonary embolism.
Takeaway
This study looks at how two treatments for a serious lung problem called pulmonary embolism can help patients feel better and live longer.
Methodology
The review involved an extensive literature search on MEDLINE to identify clinical trials related to pulmonary embolism treatments.
Limitations
The review highlights a lack of large prospective RCTs comparing catheter-directed therapy with other treatments.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website